Skip to main content
Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · IEX Real-Time Price · USD
8.30
+0.26 (3.23%)
May 17, 2024, 3:50 PM EDT - Market closed

Burning Rock Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
537.44563.24507.86429.9381.68208.87
Revenue Growth (YoY)
-4.58%10.90%18.13%12.64%82.74%-
Cost of Revenue
174.21183.2143.72115.98108.3473.81
Gross Profit
363.23380.04364.15313.92273.33135.06
Selling, General & Admin
685.53938.58793.35462.39285.49191.16
Research & Development
347.02421.87367.86263.94156.94105.3
Operating Expenses
1,0331,3601,161726.33442.43296.46
Operating Income
-669.32-980.41-797.06-412.41-169.09-161.4
Interest Expense / Income
0-0.11.540.678.9917.95
Other Expense / Income
-18.02-11.06-2.8-5.84-8.93-1.85
Pretax Income
-651.3-969.25-795.8-407.24-169.16-177.5
Income Tax
2.391.990.9000
Net Income
-653.69-971.23-796.7-407.24-169.16-177.5
Preferred Dividends
00064.69165.0154.85
Net Income Common
-653.69-971.23-796.7-471.92-334.17-232.35
Shares Outstanding (Basic)
1021041046924-
Shares Outstanding (Diluted)
1021041046924-
Shares Change
-1.46%-0.29%51.83%180.86%--
EPS (Basic)
-63.80-93.50-76.50-68.80--
EPS (Diluted)
-63.80-93.50-76.50-68.80--
Free Cash Flow
-263.8-524.68-688.24-148.47-273.28-173.23
Free Cash Flow Per Share
-25.76-50.49-66.05-21.63-111.83-
Gross Margin
67.59%67.47%71.70%73.02%71.61%64.66%
Operating Margin
-124.54%-174.07%-156.94%-95.93%-44.30%-77.27%
Profit Margin
-121.63%-172.44%-156.87%-109.77%-87.55%-111.24%
Free Cash Flow Margin
-49.09%-93.15%-135.52%-34.54%-71.60%-82.94%
EBITDA
-517.9-845.25-746.5-373.26-128.81-134.87
EBITDA Margin
-96.37%-150.07%-146.99%-86.82%-33.75%-64.57%
Depreciation & Amortization
133.4124.147.7733.3131.3624.68
EBIT
-651.3-969.35-794.26-406.57-160.17-159.55
EBIT Margin
-121.19%-172.10%-156.39%-94.57%-41.96%-76.39%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).